HomeSUVEN • NSE
add
Suven Life Sciences Ltd
Previous close
₹215.41
Day range
₹206.36 - ₹218.80
Year range
₹82.95 - ₹219.55
Market cap
45.34B INR
Avg Volume
1.33M
P/E ratio
-
Dividend yield
-
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 14.67M | -38.50% |
Operating expense | 466.34M | 40.71% |
Net income | -439.45M | -65.58% |
Net profit margin | -3.00K | -169.21% |
Earnings per share | — | — |
EBITDA | -437.20M | -45.08% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 600.05M | -74.98% |
Total assets | 1.35B | -52.55% |
Total liabilities | 251.96M | 69.54% |
Total equity | 1.10B | — |
Shares outstanding | 217.55M | — |
Price to book | 42.57 | — |
Return on assets | — | — |
Return on capital | -74.56% | — |
Cash Flow
Net change in cash
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -439.45M | -65.58% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1989
Website
Employees
141
